Expression of glutathione-S-transferases isoenzymes and p53 in exfoliated human bladder cancer cells

Urologic Oncology: Seminars and Original Investigations

Volumn 29, Issue 5, 2011, Pages 538-544

  Oǧuztüzün, Serpil ^a   Sezgin, Yasemin ^b   Yazci, Sertaç ^b   Firat, Pinar ^b   Özhavzali, Müzeyyen ^a   Özen, Haluk ^b  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Bladder cancer; Cytology; Glutathione S transferase; Immunocytochemistry; P53

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE ALPHA; GLUTATHIONE TRANSFERASE M4; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; BENIGN TUMOR; BLADDER CARCINOMA; CANCER CYTODIAGNOSIS; CANCER PATIENT; CARCINOMA CELL; CELL GRANULE; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CELL STRUCTURE; CENTRIFUGATION; CHROMATIN; CONTROLLED STUDY; CYTOPLASM; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSITIONAL CELL CARCINOMA;

CYTODIAGNOSIS; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOENZYME TECHNIQUES; ISOENZYMES; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 80052930544     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.08.001     Document Type: Article

References (33)

1. Planz B., Striepecke E., Jakse G., et al. Use of Lewis X antigen and deoxyribonucleic acid image cytometry to increase sensitivity of urinary cytology in transitional cell carcinoma of the bladder. J Urol 1998, 159:384-388.
2. Lotan Y., Roehrborn C.G. Sensitivity and specificity of commonly available bladder tumor markers versus cytology: Results of a comprehensive literature review and meta-analyses. Urology 2003, 61:109-118.
3. Eagan J.W. Urinary tract cytology. Uropathology 1989, 873-934. Churchill Livingstone, Edinburgh. G.S. Hill (Ed.).
4. Li D., Wang M., Dhingra K., et al. Aromatic DNA adducts in adjacent tissues of breast cancer patients: Clues to breast cancer etiology. Cancer Res 1996, 56:287-293.
5. Hayes J.D., Flaagan J.U., Jowsey I.R. Glutathione-S-transferases. Annu Rev Pharmacol Toxicol 2005, 45:51-88.
6. Coles B.F., Kadlubar F.F. Detoxification of electrophilic compounds by glutathione S-transferase catalysis: Determinants of individual response to chemical carcinogens and chemotherapeutic drugs?. Biofactors 2003, 17:115-130.
7. Feng Z., Hu W., Rom W.N., et al. Aminobiphenyl is a major etiological agent of human bladder cancer: Evidence from its DNA binding spectrum in human p53 gene. Carcinogenesis 2002, 23:1721-1727.
8. Aktas D., Ozen H., Atsu N., et al. Glutathione S-transferase M1 gene polymorphism in bladder cancer patients: A marker for invasive bladder cancer?. Cancer Letters 2001, 125:1-4.
9. Hung R.J., Boffetta P., Brennan P., et al. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer 2004, 110:598-604.
10. Hayes J.D., Strange R.C. Glutathione-S-transferase polymorphisms and their biological consequences. Pharmacology 2000, 61:154-166.
11. Tsuchida S., Sato K. Glutathione transferases and cancer. Crit Rev Biochem Mol Biol 1992, 27:337-384.
12. Giralt M., Lafuente A., Pujol F., et al. Enhanced glutathione S-transferase activity and glutathione content in human bladder cancer. Follow-up study: Influence of smoking. J Urol 1993, 149:1452-1454.
13. Berendsen C.L., Peters W.H.M., Scheffer P.G., et al. Glutathione-S-transferase activity and subunit composition in transitional cell cancer and mucosa of the human bladder. Urology 1997, 49:644-651.
14. Simic T., Mimic-Oka J., Savic-Radojevic A., et al. Glutathione-S-transferase T1-1 activity up-regulated in transitional cell carcinoma of urinary bladder. Urology 2005, 65:1035-1040.
15. Savic-Radojevic A., Mimic-Oka J., Pljesa- Ercegovac M., et al. Glutathione S-transferase-P1 expression correlates with increased antioxidant capacity in transitional cell carcinoma of the urinary bladder. Eur Urol 2007, 52:470-477.
16. Hainaut P., Hollstein M. p53 and human cancer: The first ten thousand mutations. Adv Cancer Res 2000, 77:81-137.
17. Hainaut P., Hernandez T., Robinson A., et al. IARC database of p53 gene mutations in human tumors and cell lines: Updated compilation, revised formats, and new visualization tools. Nucleic Acids Res 1998, 26:205-213.
18. Brockmöller J., Kaiser R., Kerb R., et al. Polymorphic enzymes of xenobiotic metabolism as modulators of acquired P53 mutations in bladder cancer. Pharmacogenetics 1996, 6:535-545.
19. Spruck C.H., Rideout W.H., Olumi A.F., et al. Distinct pattern of p53 mutations in bladder cancer. Cancer research 1993, 53:1162-1166.
20. Fujimoto K., Yamaha Y., Okajşma E., et al. Frequent association of p53 gene mutations in bladder cancers and urine samples. Science 1991, 252:706-709.
21. Frost J. The cell in health and disease. An evaluation of cellular morphologic expression of biologic behavior. Monographs in Clinical Cytology 1986, Karger, Basel. 2nd ed. G. Wied, E. von Hamm, L. Koss (Eds.).
22. Kern W. Urinary tract. A Manual of Cytotechnology 1983, ASCP Press, Chicago. 6th ed. C. Keebler, J. Reagan (Eds.).
23. Stewart B.W., Kleihus P. World cancer report 2003, IARC Press, Lyon, France.
24. Stern M.C., Johnson L.R., Bell D.A., et al. XPD colon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2002, 11:1004-1011.
25. Sanyal S., Festa F., Sakano S., et al. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 2004, 25:729-734.
26. Their R., Golka K., Brüning T., et al. Genetic susceptibility to environmental toxicants: The interface between human and experimental studies in the development of new toxicological concepts. Toxicol Lett 2002, 127:321-327.
27. Lafuente A., Giarlt M., Cervello I., et al. Glutathione S-transferase activity in human superficial transitional cell carcinoma of the bladder. Comparison with healthy controls. Cancer 1990, 665:2064-2068.
28. Singh S.V., Xu B.H., Tkalevic G.T., et al. Glutathione-linked detoxification pathway in normal and malignant human bladder tissue. Cancer Lett 1994, 77:15-24.
29. Singh S.V., Ahmad H., Krishan A. Expression of glutathione related enzymes in human bladder cancer cell lines. Biochem Pharmacol 1990, 39:1817-1820.
30. Ahn H., Lee E., Kim K., et al. Effect of glutathione and its related enzymes on chemosensitivity of renal cell carcinoma and bladder carcinoma cell lines. J Urol 1994, 151:263-267.
31. Assimakopoulos D., Kolettas E., Zagorianakou N., et al. Prognostic significance of p53 in the cancer of the larynx. Anticancer Res 2000, 20:3555-3564.
32. Lipponen P.K. Overexpression of p53 nuclear oncoprotein in transitional cell bladder cancer and its prognostic value. Int J Cancer 1993, 53:365-370.
33. Esrig D., Elmajian D., Groshen S., et al. Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 1994, 331:1259-1264.